Abstract Cardiogenic shock occurs in 2.5% patients with non ST elevation myocardial infarction as compared to 5-8% of patients with ST elevation myocardial infarction. Percutaneous coronary intervention for ischemia related cardiogenic shock in patients with myelodysplastic syndrome and thrombocytopenia presents a unique challenge for the interventional cardiologist and hematologist. The patient in our case report presented with non ST elevation myocardial infarction, severe thrombocytopenia and cardiogenic shock. He had in-stent restenosis in prior bare metal stents and was declined for coronary artery bypass grafting (CABG), limiting the treatment options. This is the first case report of percutaneous coronary intervention for in-stent restenosis in myelodysplastic syndrome. The procedure was successful and patient did well on one year follow up.
Keywords: percutaneous coronary intervention (PCI); thrombocytopenia; myelodysplastic syndrome (MDS)